Atlas Trials

Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies

Clinical trial NCT01168882 · WITHDRAWN

Trial details

NCT number
NCT01168882
Sponsor
Agennix
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hematological Malignancies
Start date
2011-11-01
Primary completion
2014-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.